T 0210/11 (PHARMACEUTICAL NANOPARTICULATE COMPOSITION OF A TACHYKININ RECEPTOR ANTAGONIST/Merck Sharp & Dohme) of 17.07.2014

European Case Law Identifier: ECLI:EP:BA:2014:T021011.20140717
Date of decision: 17 July 2014
Case number: T 0210/11
Petition for review of: -
Application number: 02796109.3
IPC class: A61K 9/51 A61K 9/14 A61K 31/5377 A61K 9/16
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: PHARMACEUTICAL NANOPARTICULATE COMPOSITION OF A TACHYKININ RECEPTOR ANTAGONIST
Applicant name: Merck Sharp & Dohme Corp.
Opponent name: Hexal AG
Teva Pharmaceutical Industries Ltd.
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 100(b)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54 European Patent Convention Art 56 European Patent Convention Art 84
Keywords: Amendments - broadening of claim (no)
Amendments - added subject-matter (no)
Claims - clarity
Claims - main request (yes)
Grounds for opposition - insufficiency of disclosure (no)
Novelty - (yes)
Inventive step - (yes)
Reimbursement of appeal fee - (no)
Catchword: -
Cited cases: -
Citing cases: T 0908/15 T 0488/16 T 0769/18

Order

For these reasons it is decided that:

The appeals are dismissed.